ReShape Lifesciences receives notice of allowance for U.S. patent on Obalon

ReShape Lifesciences announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office for patent application 16/792,094, entitled, "Systems and Methods for Determining Failure of Intragastric Devices," related to its Obalon Balloon System. The patent will cover additional claims for the Obalon Balloon System and is expected to provide protection into at least January 2031, without accounting for a potential Patent Term Extension.